Andrea Guffanti

Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy

Luca Baldini, Andrea Guffanti, BM Cesana et al. · Blood · 1996 · 124 citations · Full text

Medicine, Hematology, Oncology +15

Treatment and prognosis in a series of primary extranodal lymphomas of the ocular adnexa

Luca Baldini, M Blini, Andrea Guffanti et al. · Annals of Oncology · 1998 · 83 citations · Full text

Medicine, Oncology, Ophthalmology +12

Immunoglobulin M Monoclonal Gammopathies of Undetermined Significance and Indolent Waldenström's Macroglobulinemia Recognize the Same Determinants of Evolution Into Symptomatic Lymphoid Disorders: Proposal for a Common Prognostic Scoring System

Luca Baldini, Maria Goldaniga, Andrea Guffanti et al. · Journal of Clinical Oncology · 2005 · 81 citations · Full text

Veterinary Medicine, Hematology, Internal Medicine +16

Peripheral neuropathy in IgM monoclonal gammopathy and wäldenstrom's macroglobulinemia: A frequent complication in elderly males with low MAG‐reactive serum monoclonal component

Luca Baldini, Eduardo Nobile‐Orazio, Andrea Guffanti et al. · American Journal of Hematology · 1994 · 68 citations

Medicine, Immunology, Neurology +17

Poor prognosis in non‐villous splenic marginal zone cell lymphoma is associated with p53 mutations

Luca Baldini, Andrea Guffanti, Nicola Stefano Fracchiolla et al. · British Journal of Haematology · 1997 · 30 citations · Full text

Medicine, Oncology, Pathology +16